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Section A 
 
Short Essay Questions 
 





This section should be answered in the Answer Booklet provided. 
 






Marks for each question are indicated. 






Describe and compare these two infections: meningitis and encephalitis 
 
Your description should include the definition, pathogenesis & likely causative 
pathogens, risk factors that predispose an individual to these infections, prognosis and 















(Your discussion should include the mode of action, spectrum of antimicrobial activity 
and any other factors which need to be considered while using the agent.) 
 
(Marks 5 + 5 + 5 = 15) 
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Briefly discuss the resistance mechanism of any THREE of the following antimicrobial 
agents. 
 
Your discussion should include the resistance mechanism(s) that microorganisms have 
developed against each of the agents, and the clinical importance of preventing the 












a)  Briefly discuss the pathogenesis of acute pyelonephritis. 
 
b)  Outline the important principles for identifying the causative pathogen(s) in infectious 
endocarditis. Suggest a first line empirical regimen for infectious endocarditis, and 
justify your choice. 
 












(Your discussion should include pathogenesis, presentation, clinical and social 
significance, if applicable.) 
 
(Marks 7.5 + 7.5 = 15) 
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Briefly discuss the infectious disease community acquired pneumonia in the Darwin 
region. 
 
Your discussion should include the definition, pathogenesis & likely causative 
pathogens, risk factors that predispose an individual to these infections, prognosis and 







a)  Discuss the factors that can contribute or predispose an individual to the development 
of osteomyelitis. 
 
b)  Discuss the common organism(s) that is associated with osteomyelitis, and the first 
line empirical therapy for osteomyelitis. (Your discussion should also include any 
important consideration when treating osteomyelitis) 
 
(Marks 7 + 8 = 15) 
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Section B 
 
Case Study Based Questions 
 









Marks for each question are indicated. Suggested 







Mrs CP is an 75-year old female with a medical history of cardiovascular diseases 
(hypertension, high cholesterol, and a mild stroke 4 years ago) and arthritis, but she is 
otherwise relatively healthy and independent for all personal activities of daily living. Her 
current regular medications include ramipril, low dose aspirin, atorvastatin, paracetamol 
and oxycodone. 
 
Mrs CP has been experiencing influenza-like symptoms and feeling generally unwell for 
about a week prior to presentation, with difficulty in breathing. Mrs CP has a non-
productive cough and describes pain in her chest, both front and back, which she thinks 
may be due to a recent injury to her chest. 
 
On examination, Mrs CP is found to be moderately dehydrated. Physical examination 
and chest X-ray (CXR) show evidence of right middle lobe consolidation but the 
remainder of the chest is clear. 
 
BP = 118/63, HR 90 bpm, RR 18 breath/min, temperature 37.4°C, SatO2 87% 
 
RCC 4.05, Plt 168, WCC 14.2, neutrophil 11.90, Lymphocytes 0.65, Monocytes 
 
0.13; Na 134, K 3.6, eGFR 37, CRP 280 
 
A sputum sample is collected and sent for MCS testing. Preliminary results indicated a 
mixed growth of polymorphs and normal oral flora. A second sputum sample was 
ordered. 
 
Mrs CP is diagnosed with community acquired pneumonia. 
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Questions 
 
A. Discuss are the presenting symptoms and findings in Mrs CP that confirm or 
associate with the diagnosis of community acquired pneumonia? Briefly discuss the 
significant/ severity of the condition in Mrs CP based on information currently 
available. 
 





B. Identify and briefly describe THREE pathogens that are most commonly associated 






C. Briefly describe the pathogenesis of community acquired pneumonia in Mrs CP. 
(Your discussion should include the development of infection, risk factor found in 
 






D. What empirical therapy whould you recommend for the treatment of Mrs CP? 




(Total: 30 marks) 
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Question B2 
 
Mrs UC is a 63-year old female with Australian background and lives with her daughter. 
Mrs UC is a smoker, and was diagnosed with Type II Diabetes Mellitus (from 
2010) and GORD. Her regular medications include metformin 1 g daily, aspirin 100 mg 
daily, pantoprazole 20 mg daily, and perindopril 2.5 mg daily. Mrs UC is allergic to 
penicillin, which can cause a severe rash and laryngeal oedema to develop if she is 
exposed to chemically related agents. 
 
Mrs UC visits her GP after experiencing difficulties in passing urine. She describes the 
symptoms as pain during urination (dysuria) and lower abdominal pain. She also 
describes having loose stool (or mild diarrhoea) for the past 2 days. 
 
On examination, Mrs UC is alert and afebrile. Chest examination is clear, and there is no 
abdominal mass or tenderness. 
 
BP = 134/78, HR 81 bpm. 
 
Urine test: sample is cloudy, protein +1, nitrite +ve, pH 7.1, WCC 104, RCC -ve 
 
Blood and urine samples are collected and sent for MCS. 
 








A. Discuss the presenting symptoms and examination findings that suggest Mrs UC 
may have cystitis. Use these information to draw conclusions about the diagnosis, 







B. Outline a management plan that you would recommend for Mrs UC. 
(Explain the rationale behind the empirical therapy that was initiated; 
why was cephalexin selected? Was this a good choice? What is the 
risk of cross-reactivity? 
 
(Marks 10) 
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Mrs UC developed an anaphylactic reaction within an hour of taking the treatment for 
her UTI (treatment you have recommended in Question B2-B). She is treated by 







C. After the incidence, what antimicrobial therapy would you recommend for the 
treatment of Mrs UC’s UTI? 
 
(Your answer should also include the rationale for your recommendation and any 
specific consideration(s).) 
 
(Marks: 5)  
 
 
(Total: 20 marks) 
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Question B3 
 
Mr SA is a 68 years old Aboriginal male presented to his local hospital with an infected 
right heel. Mr SA has a medical history of type II DM, hypertension and chronic kidney 
disease. According to his GP’s referral letter, the infection started after he was bitten by 
an unknown insect about a week ago, and the bite wound did not improve after a course 
of oral antibiotics therapy (flucloxacillin). 
Surgical drainage of the pus and debridement was performed on the next day (on 
22th July 2014), and samples were sent for MCS test. Intravenous empirical antibiotic 






A. Discuss the pathogenesis of Mr SA’s wound infection, and comment on the antibiotics 
used. 
 
(Your discussion should include the development of the infection, risk factors and 








One day after the surgery, the MCS result has become available: 
Organism: Staphylococcus aureus +++ 
 
• Amoxicillin/Clavulanic acid R 
 
• Clindamycin I 
 
• Cephalotin R 
 
• Flucloxacillin R 
 
• Rifampicin S 
 
• Ticarcillin I 
 
• Vancomycin S 
 
Susceptibilities (S = susceptible; R = resistant; I = intermediate; N = not 
performed) 
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The doctor decided to change Mr SA’s antibiotic therapy to iv vancomycin 2 g daily, with 
a target trough level of 10-15 mcg/mL. Three days after the initiation of new antibiotic, his 





Date 26/07 22/07 04/03 01/03 18/02 
Cr (umol/L) 123 93 98 84 106 
eGFR 51 70 66 79 60 
ALT 19    22 









B. Taking his condition into consideration and the laboratory findings, what would be 
your recommendation regarding the vancomycin use in Mr SA? Justify your 
recommendation and outline any additional monitoring that may be required. 
(Mr SA is about 162 cm tall and weighs 61 kg) 
 
(Marks 15) 
(Total: 25 marks) 
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Reference ranges for laboratory tests 
 
(Slight variations exist among laboratory due to the method of analysis) 
 
 
Urea and electrolytes (U&E) 
Na 135.0-145.0  mmol/L 
K 3.50-4.50  mmol/L (plasma)  
 3.8-4.9  mmol/L (serum)  
Cl 95-110  mmol/L 
HCO3- 22-32  mmol/L 
Urea 3.8-8.0 mmol/L 
Creatinine 60-100 mmol/L 
eGFR > 90 mL/min/1.73 m2 
 
 
Full blood examination (FBE) 
Hb 135-185  g/L (male)  
 115-165  g/L (female) 
RCC 4.50-6.50  (x10 12 /L) 
Haematocrit 0.40-0.54      %  
MCV 78.0-100.0    fL  
RDW 11.5-14.5      %  
Platelets (Plt)Palet 150-450   (x109 /L)  
WCC 4.0-11.0         (x10 9/L) 
Neutrophil 2.0-7.5   (x10 9 /L) OR 40-80% 
Lymphocytes 1.5-4.0  (x10 9 /L) OR 20-40%  
Monocytes 0.2-0.8  (x10 9 /L) OR 2-10%  
Eosinophils 0.0-0.4  (x10 9 /L) OR 1-6%  
Basophils 0.0-0.1  (x10 9 /L) OR <2% 
 
 
Liver function tests (LFT) 
ALP 20-100  U/L  
AST <40   U/L 
ALT <35   U/L  
GGT <50   U/L  
Total bilirubin 0-20   umol/L  
Total protein 61-84   g/L  
Alb 35-45   g/L 
Creatine Kinase (CK) 60-220  U/L  (male)  
 30-180  U/L   
(female) CRP <3 mg/L 
 
